Table 2 Comparison of baseline characteristics in the unmatched and the matched data
Characteristics | Unmatched data | Matched data | ||||
|---|---|---|---|---|---|---|
No. (%) | No. (%) | |||||
AbiRT (N = 30) | Non-AbiRT (N = 119) | P | AbiRT (N = 30) | Non-AbiRT (N = 58) | P | |
Age, years | Â | Â | 0.224 | Â | Â | 0.440 |
 ≤ 65 | 15 (50.0) | 45 (37.8) |  | 15 (50.0) | 24 (41.3) |  |
 > 65 | 15 (50.0) | 74 (62.2) |  | 15 (50.0) | 34 (58.6) |  |
PSA at mCRPC | Â | Â | 0.005 | Â | Â | 0.667 |
 ≤ 20 ng/mL | 23 (76.6) | 57 (47.9) |  | 23 (76.6) | 42 (72.4) |  |
 > 20 ng/mL | 7 (23.3) | 62 (52.1) |  | 7 (23.3) | 16 (27.6) |  |
Gleason score | Â | Â | 0.435 | Â | Â | 0.886 |
 ≤ 8 | 16 (53.3) | 54 (45.4) |  | 16 (53.3) | 30 (51.7) |  |
 9–10 | 14 (46.6) | 65 (54.6) |  | 14 (46.6) | 28 (48.3) |  |
Prognostic index | Â | Â | 0.107 | Â | Â | 0.227 |
 Good | 17 (56.6) | 48 (40.3) |  | 17 (56.6) | 25 (43.1) |  |
 Intermediate/poor | 13 (43.3) | 71 (59.7) |  | 13 (43.3) | 33 (56.9) |  |
Oligometastasis | 19 (63.3) | 39 (32.8) | 0.002 | 19 (63.3) | 36 (62.1) | 0.908 |
Synchronous metastasis | 24 (80.0) | 103 (86.6) | 0.538 | 24 (80.0) | 48 (82.8) | 0.750 |
Chemo-naïve | 28 (93.3) | 95 (79.8) | 0.082 | 28 (93.3) | 53 (91.4) | 1.000 |